drugset / Trial / NCT04145076

Brain Response to Serotonergic Medications in ASD

NCT04145076

Unknown 100 enrolled King's College London
RandomizedCrossoverDouble-blindBasic science

Summary

This study investigates brain response to single acute dose of citalopram, tianeptine, and placebo in males with and without autism spectrum disorder.

Timeline

Start
2014-12-15
Primary completion
2023-02
Completion
2023-05-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Citalopram Small molecule 20 mg Oral
Subject Tianeptine Small molecule 12.5 mg Oral